Phenotypic plasticity and the epigenetics of human disease
Top Cited Papers
- 23 May 2007
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 447 (7143) , 433-440
- https://doi.org/10.1038/nature05919
Abstract
It is becoming clear that epigenetic changes are involved in human disease as well as during normal development. A unifying theme of disease epigenetics is defects in phenotypic plasticity — cells' ability to change their behaviour in response to internal or external environmental cues. This model proposes that hereditary disorders of the epigenetic apparatus lead to developmental defects, that cancer epigenetics involves disruption of the stem-cell programme, and that common diseases with late-onset phenotypes involve interactions between the epigenome, the genome and the environment. Increased understanding of epigenetic-disease mechanisms could lead to disease-risk stratification for targeted intervention and to targeted therapies.Keywords
This publication has 94 references indexed in Scilit:
- Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9Nature, 2006
- Polycomb complexes repress developmental regulators in murine embryonic stem cellsNature, 2006
- A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem CellsCell, 2006
- The epigenetic progenitor origin of human cancerNature Reviews Genetics, 2006
- Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cellsNature Genetics, 2005
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005
- Epigenetic programming by maternal behaviorNature Neuroscience, 2004
- The history of cancer epigeneticsNature Reviews Cancer, 2004
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumourNature, 1993